ArticleJournal of imaging informatics in medicine2026
Enhanced CT-Based Delta-Radiomics: Predicting Lymphovascular and Perineural Invasion in Rectal Cancer Preoperatively.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
To construct and validate a multi-phase contrast-enhanced computed tomography delta-radiomics signature for preoperatively predicting lymphovascular invasion (LVI) and perineural invasion (PNI) in patients with rectal cancer (RC). This study retrospectively enrolled 519 patients with RC between January 2017 and December 2022, with patients assigned to the training (n = 363) or validation (n = 156) sets. Radiomic features were extracted from routine scanning (A0), the arterial phase (A1), and the venous phase (A2). Delta-1 and Delta-2 radiomic signatures were derived by subtracting radiomic features acquired from A0 images from those of A2 and A1, respectively. Subsequently, Delta-3 and Delta-4 radiomic features were obtained by performing image subtraction between the A0 images and A2 and A1 images, then extracting the radiomic features from the resulting residual images. A delta-radiomics model was constructed using the Least Absolute Shrinkage and Selection Operator method. Model performance was evaluated using receiver operating characteristic, calibration, and decision curves. Delta-1-Delta-4 models exhibited moderate predictive performance for LVI and PNI in patients with RC, with area under the curve (AUC) values of 0.73, 0.73, 0.67, and 0.68, respectively. The combined model (C-Delta-12) showed the best predictive performance (AUC, 0.81; accuracy, 0.76; sensitivity, 0.86; specificity, 0.65). Calibration curves confirmed high goodness of fit, and decision curve analysis confirmed the clinical value. Integrating delta-radiomics signature and clinical predictors into a radiomics prediction model enables accurate and non-invasive risk assessments of PNI and LVI in RC. Stratifying patients based on their PNI and LVI status may facilitate more individualised treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.